Total Funding
1
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Calando Pharmaceuticals focuses on creating targeted therapeutics for the development of nanoparticle drug formulations.
- Mark E. Davis: Founder
About the Company
Calando Pharmaceuticals is a biopharmaceutical company focused on creating targeted therapeutics using its patented and proprietary cyclodextrin-based polymer technologies for the development of nanoparticle drug formulations.
Calando’s initial emphasis has been to bring targeted siRNA and small molecule therapeutics to the clinic for oncology
applications; however, the technologies are not limited to these classes of molecules and are applicable to a very broad range of therapeutic entities and diseases.
